Latest Intellectual Property News

Streamplay’s subsidiary Noodlecake has inked a three-year licensing agreement with Amazon to adapt and distribute one of its owned games on Amazon’s gaming platform, marking a strategic expansion into a new marketplace.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

INOVIQ Limited clarifies recent share price movements, confirming no undisclosed material information while highlighting an imminent ASCO presentation and provisional patent application tied to its EXO-OC ovarian cancer test.

Smartpay has reported an 8.5% rise in consolidated revenue for FY2025, driven by growth in Australia and a bold entry into New Zealand’s acquiring market. However, investments in technology and market expansion have weighed on EBITDA.

InFocus Group Holdings has secured a $3.25 million contract to develop a cutting-edge white-label iGaming platform for Taiwanese firm TG Solutions, marking a significant expansion into the digital gaming sector.

Recce Pharmaceuticals has secured a significant patent acceptance in China for its RECCE® anti-infectives, broadening its intellectual property footprint in the world’s second-largest pharmaceutical market.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

Argenica Therapeutics has expanded its intellectual property with a new US patent targeting surgically induced strokes, enhancing the commercial potential of its lead drug candidate ARG-007.

Nufarm Limited reported a 3% revenue increase to $1.81 billion for the half-year ended March 2025, driven by Crop Protection volume growth. However, net profit after tax fell 39% amid fish oil pricing pressures and higher operating costs, prompting the board to withhold an interim dividend.

Nufarm Limited posted a 3% revenue increase to $1.81 billion for the half-year ending March 2025, driven by Crop Protection growth, yet profits fell sharply due to omega-3 inventory write-downs and higher costs. The company withheld its interim dividend amid ongoing operational challenges.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

A shareholder has lodged a formal application with the Takeovers Panel challenging FBR Limited’s recent share placements and governance practices, raising concerns over disclosure and shareholder engagement.